Among all the tRCC types, patients with ASPSCR1 fusion have the most unfavorable prognosis and lymph node metastasis is more common; however, the correlation between fusion type and prognosis is unclear28. This evidence concerns the gene ASPSCR1 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.